covid-19. Severe Acute Respiratory Syndrome coronavirus
Conditions
Interventions
Intervention 1: Intervention group: non-hospitalization patients with symptomatic COVID-19 received 1. Artemisia annua - Artemisinin ( Manufactured by Longlifenutri)150 mg every 24 hours 2. Dose of 1
Sponsors
Sirjan Faculty of Medical Science
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: COVID-19 virus infection by RT-PCR in non-hospitalization and hospitalization patients G6PD sufficient in non-hospitalization and hospitalization patients Lack of clinical response to routine outpatient treatment in non-hospitalization and hospitalization patients Clinical symptoms (fever, cough, myalgia, shortness of breath, digestive problems) in non-hospitalization and hospitalization patients Age over 12 years in non-hospitalization and hospitalization patients Patient satisfaction in non-hospitalization and hospitalization patients Lymphocytes less than 15%, respiratory distress, lung involvement on CT scan, oxygen level less than 93%, unstable vital signs, severe gastrointestinal symptoms and oral intolerance, underlying disease Except for exclusion cases hospitalization patients
Exclusion criteria
Exclusion criteria: Allergy to oral supplements and high doses of vitamin C Reluctance to continue participating in the trial for any reason Patients admitted to the intensive care unit (ICU) (patients who have been admitted to the ICU since admission) Pregnant and lactating lady Patients with seizures Dialysis patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDH. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Blood Test.;CBC diff. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Blood Test.;Na/K/Ca. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Blood Test.;CRP. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Blood Test.;ESR1. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Blood Test.;Weakness and nausea. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: Check List.;Lung involvement. Timepoint: Before the intervention and ten days after the intervention. Method of measurement: CT-Scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determination of the effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on on oxygen. Timepoint: 10 day. Method of measurement: Pulse Oximeter.;General condition of people and vitality after treatment. Timepoint: 10 day. Method of measurement: Examination and history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Ali,Amjadi
Sirjan Faculty of Medical Science
Outcome results
None listed